The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million
The policy directive for the Small Business Innovation Research and Small Business Technology Transfer programs (collectively, “SBIR”) was updated,
Continue Reading SBIR Policy Directive Update Preserves Government Contracting Benefits in Acquisition